UA81493C2 - Crystal of benzimidazole derivative and process for producing the same - Google Patents

Crystal of benzimidazole derivative and process for producing the same

Info

Publication number: UA81493C2
Authority: UA; Ukraine
Prior art keywords: crystal; producing; same; benzimidazole derivative; crystals
Prior art date: 2003-05-14

Application number

UAA200511908A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-14

Filing date

2004-05-14

Publication date

2008-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33447189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81493(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-05-14 Application filed filed Critical

2008-01-10 Publication of UA81493C2 publication Critical patent/UA81493C2/xx

Links

239000013078 crystal Substances 0.000 title abstract 3
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title abstract 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

UAA200511908A 2003-05-14 2004-05-14 Crystal of benzimidazole derivative and process for producing the same UA81493C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003135567		2003-05-14
PCT/JP2004/006887 WO2004101551A1 (fr)	2003-05-14	2004-05-14	Cristaux de derive de benzimidazole et leur procede de preparation

Publications (1)

Publication Number	Publication Date
UA81493C2 true UA81493C2 (en)	2008-01-10

Family

ID=33447189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200511908A UA81493C2 (en)	2003-05-14	2004-05-14	Crystal of benzimidazole derivative and process for producing the same

Country Status (25)

Country	Link
US (1)	US7649008B2 (fr)
EP (1)	EP1626048A4 (fr)
JP (1)	JPWO2004101551A1 (fr)
KR (1)	KR20060011997A (fr)
CN (1)	CN1788007A (fr)
AR (1)	AR044340A1 (fr)
AU (1)	AU2004238708A1 (fr)
BR (1)	BRPI0410266A (fr)
CA (1)	CA2523978A1 (fr)
CL (1)	CL2004001034A1 (fr)
CO (1)	CO5660259A2 (fr)
EC (1)	ECSP056162A (fr)
IS (1)	IS8177A (fr)
MA (1)	MA27805A1 (fr)
MX (1)	MXPA05011851A (fr)
NO (1)	NO20055181L (fr)
NZ (1)	NZ542978A (fr)
PE (1)	PE20050203A1 (fr)
RU (1)	RU2332417C2 (fr)
SA (1)	SA04250117B1 (fr)
TN (1)	TNSN05288A1 (fr)
TW (1)	TW200505911A (fr)
UA (1)	UA81493C2 (fr)
WO (1)	WO2004101551A1 (fr)
ZA (1)	ZA200508640B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2004001034A1 (es)	2003-05-14	2005-03-28	Teijin Pharma Ltd	Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
KR20060120601A (ko) *	2003-08-22	2006-11-27	데이진 화-마 가부시키가이샤	키마제 저해제를 유효 성분으로서 함유하는 약제
JPWO2006052026A1 (ja) *	2004-11-12	2008-05-29	帝人ファーマ株式会社	ベンズイミダゾール誘導体の酸性塩及びその結晶
JP2016150917A (ja) *	2015-02-17	2016-08-22	株式会社トクヤマ	バルサルタンの結晶の製造方法
WO2022257845A1 (fr) *	2021-06-11	2022-12-15	苏州科睿思制药有限公司	Forme cristalline du tolebrutinib, son procédé de préparation et son utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0237608B1 (fr)	1986-03-21	1992-01-29	HEUMANN PHARMA GMBH & CO	La forme sigma cristalline, anhydre de 2-[4-(2-furoyl-(2-pipérazin)-1-yl]-4-amino-6,7-diméthoxyquinazoline hydrochlorure et procédé pour sa préparation
US5015646A (en)	1987-08-28	1991-05-14	Bristol-Myers Squibb Co.	Pharmaceutically useful polymorphic modification of buspirone
KR100287579B1 (ko)	1994-05-31	2001-05-02	야스이 쇼사꾸	나프탈렌유도체
ES2150353B1 (es)	1998-04-15	2001-07-01	Esteve Labor Dr	Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
US20040010004A1 (en) *	2000-01-17	2004-01-15	Naoki Tsuchiya	Benzimidazole derivatives
HUP0103256A3 (en)	1998-07-15	2002-05-28	Teijin Ltd	Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
ES2295128T3 (es)	2000-01-17	2008-04-16	Teijin Pharma Limited	Derivados de bencimidazol como inhibidores de quimasa humana.
EP1362854B1 (fr)	2001-02-22	2007-10-31	Teijin Pharma Limited	Dérivé benzo[b]thiophène et procédé de production correspondant
US6774245B2 (en)	2001-05-07	2004-08-10	Teijin Limited	3-Hydroxymethylbenzo[b]thiophene derivatives and process for their preparation
JP4173098B2 (ja) *	2001-08-24	2008-10-29	帝人株式会社	キマーゼ阻害剤及びａｃｅ阻害剤を有効成分として含有する薬剤
CL2004001034A1 (es)	2003-05-14	2005-03-28	Teijin Pharma Ltd	Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r

2004
- 2004-05-13 CL CL200401034A patent/CL2004001034A1/es unknown
- 2004-05-14 WO PCT/JP2004/006887 patent/WO2004101551A1/fr not_active Ceased
- 2004-05-14 MX MXPA05011851A patent/MXPA05011851A/es unknown
- 2004-05-14 PE PE2004000502A patent/PE20050203A1/es not_active Application Discontinuation
- 2004-05-14 CN CNA2004800127952A patent/CN1788007A/zh active Pending
- 2004-05-14 BR BRPI0410266-5A patent/BRPI0410266A/pt not_active IP Right Cessation
- 2004-05-14 KR KR1020057021506A patent/KR20060011997A/ko not_active Ceased
- 2004-05-14 CA CA002523978A patent/CA2523978A1/fr not_active Abandoned
- 2004-05-14 US US10/556,683 patent/US7649008B2/en not_active Expired - Fee Related
- 2004-05-14 RU RU2005138868/04A patent/RU2332417C2/ru not_active IP Right Cessation
- 2004-05-14 TW TW093113785A patent/TW200505911A/zh unknown
- 2004-05-14 JP JP2005506263A patent/JPWO2004101551A1/ja not_active Ceased
- 2004-05-14 AR ARP040101656A patent/AR044340A1/es unknown
- 2004-05-14 EP EP04733128A patent/EP1626048A4/fr not_active Withdrawn
- 2004-05-14 NZ NZ542978A patent/NZ542978A/en unknown
- 2004-05-14 UA UAA200511908A patent/UA81493C2/xx unknown
- 2004-05-14 AU AU2004238708A patent/AU2004238708A1/en not_active Abandoned
- 2004-05-15 SA SA4250117A patent/SA04250117B1/ar unknown
2005
- 2005-10-25 ZA ZA200508640A patent/ZA200508640B/en unknown
- 2005-11-03 NO NO20055181A patent/NO20055181L/no not_active Application Discontinuation
- 2005-11-11 CO CO05115024A patent/CO5660259A2/es not_active Application Discontinuation
- 2005-11-14 TN TNP2005000288A patent/TNSN05288A1/en unknown
- 2005-11-14 EC EC2005006162A patent/ECSP056162A/es unknown
- 2005-11-14 MA MA28603A patent/MA27805A1/fr unknown
- 2005-12-13 IS IS8177A patent/IS8177A/is unknown

Also Published As

Publication number	Publication date
CL2004001034A1 (es)	2005-03-28
TW200505911A (en)	2005-02-16
PE20050203A1 (es)	2005-03-26
US7649008B2 (en)	2010-01-19
CN1788007A (zh)	2006-06-14
BRPI0410266A (pt)	2006-05-16
SA04250117B1 (ar)	2009-09-02
CA2523978A1 (fr)	2004-11-25
TNSN05288A1 (en)	2007-07-10
US20060293375A1 (en)	2006-12-28
ZA200508640B (en)	2007-02-28
RU2332417C2 (ru)	2008-08-27
MXPA05011851A (es)	2006-02-17
MA27805A1 (fr)	2006-03-01
EP1626048A4 (fr)	2008-11-12
JPWO2004101551A1 (ja)	2006-07-13
IS8177A (is)	2005-12-13
ECSP056162A (es)	2006-04-19
NZ542978A (en)	2009-04-30
NO20055181D0 (no)	2005-11-03
AR044340A1 (es)	2005-09-07
AU2004238708A1 (en)	2004-11-25
CO5660259A2 (es)	2006-07-31
RU2005138868A (ru)	2006-07-10
KR20060011997A (ko)	2006-02-06
WO2004101551A1 (fr)	2004-11-25
NO20055181L (no)	2006-01-24
EP1626048A1 (fr)	2006-02-15

Publication	Publication Date	Title
WO2007120647A3 (fr)	2007-11-29	Compositions utiles en tant qu'inhibiteurs de canaux sodiques sensibles a la tension
NO20071617L (no)	2007-04-20	Indozolonderivater som 11B-HSD1-inhibitorer
NZ592897A (en)	2012-12-21	Crystals of laquinimod sodium, and process for the manufacture thereof
JO2282B1 (en)	2005-09-12	Oxazole derivatives
MY147994A (en)	2013-02-28	Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
JO2353B1 (en)	2006-12-12	New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
IS8230A (is)	2006-01-12	Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
NO20083708L (no)	2008-09-23	4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
GB0314967D0 (en)	2003-07-30	Piperazine derivatives
IL183636A0 (en)	2007-09-20	Quinoline derivative, use and production thereof, and drug containing the same
DK1513800T3 (da)	2007-03-26	Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
WO2003006443A3 (fr)	2003-05-01	Derives d'acide carboxylique, medicaments contenant ces composes, leur utilisation et leur production
MXPA05010020A (es)	2005-11-17	Derivados de oxamida.
SE0302756D0 (sv)	2003-10-17	Novel Compounds
NO20055257L (no)	2005-11-09	Ny fremgangsmate for syntesen av s-indolin-2-karboksylsyre og anvendelse derav i syntesen av perindopril
IL166057A0 (en)	2006-01-15	Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
MX2007011698A (es)	2008-03-11	Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
UA81493C2 (en)	2008-01-10	Crystal of benzimidazole derivative and process for producing the same
MY139159A (en)	2009-08-28	Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY138550A (en)	2009-06-30	Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139228A (en)	2009-08-28	Imidazolinylmethyl aralkylsulfonamides
MY139348A (en)	2009-09-30	Method for synthesis of perindopril and its pharmaceutically acceptable salts
TW200621703A (en)	2006-07-01	Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MY136288A (en)	2008-09-30	New process for the synthesis of perindopril and its pharmaceutically acceptable salts
AU2002247949A1 (en)	2003-10-13	Process for synthesis of trans-alkenoic acid, use thereof